United Therapeutics UTHR Cash Flow Statement (2009-2026)

NASDAQ UTHR
$520.36 -8.78 (-1.66%)
At close: Aug 20, 2026 · 10:50 AM UTC
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
162.70M112.20M239.90M116.00M239.30M132.10M240.90M259.20M267.60M217.10M306.60M278.10M309.10M301.30M322.20M309.50M338.70M364.30M274.90M333.00M
Depreciation and Depletion (Quarter)
14.80M18.60M18.80M19.40M19.60M20.90M21.50M22.70M21.60M22.80M
Share-based Compensation (Quarter)
-58.60M0.20M-21.10M32.20M30.90M-30.60M-12.40M13.80M21.10M-8.70M11.40M0.10M105.50M-104.80M15.30M0.20M93.20M-92.10M58.30M19.00M
Deferred Taxes (Quarter)
25.90M25.70M
Asset Writedowns and Impairment (Quarter)
-94.20M1.70M-5.30M
Cash from Operations (Quarter)
185.60M174.60M288.70M127.00M258.60M128.20M374.80M106.30M346.20M150.70M376.50M232.20M377.20M341.20M461.20M191.70M562.10M346.20M463.30M313.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
12.40M12.60M12.50M12.70M12.90M13.20M13.30M12.90M13.30M13.70M15.00M18.70M19.10M19.70M19.80M21.10M21.90M22.80M22.60M24.20M
Change in Working Capital
Change in Receivables (Quarter)
39.30M-14.10M-28.10M2.80M58.30M-11.30M-85.90M138.10M-14.00M20.30M28.30M-16.50M51.10M-62.50M42.70M57.30M-81.60M52.50M-38.20M-1.70M
Change in Inventory (Quarter)
8.20M0.10M-5.70M4.60M0.60M13.90M2.50M1.00M3.10M7.00M9.30M14.70M11.30M11.60M11.20M7.40M17.50M16.50M40.10M17.70M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
19.80M-34.50M-10.80M23.90M22.30M9.10M2.80M38.00M39.40M-23.10M1.90M25.80M33.00M-18.00M-2.60M46.10M31.20M23.20M-12.70M-4.00M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)
46.90M70.60M13.50M17.00M-16.70M0.70M18.40M67.60M-51.20M-16.40M23.60M59.70M76.50M86.70M74.90M-8.70M281.40M-231.30M99.60M108.00M
Change in Intangibles (Quarter)
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
958.40M366.60M131.90M378.50M-506.60M1,017.70M2,137.30M475.30M196.50M160.00M611.70M304.20M182.50M485.50M1,307.90M
Cash from Investing Activities (Quarter)
87.50M
Financing Activities
Other financing activities (Quarter)
126.30M
Cash from Financing Activities (Quarter)
122.40M
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
523.50M
Free Cash Flow (Quarter)
205.60M
Net Cash Flow (Quarter)
523.50M